Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Oral Science

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2334/JOSNUSD.47.71PMID 16050486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunolocalization of c-Fos and c-Jun in human oral mucosa and in oral squamous cell carcinoma.

  2002cited by this paper
• Promoter Specificity and Biological Activity of Tethered AP-1 Dimers

  2002cited by this paper
• Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth

  2002cited by this paper
• Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes.

  2001cited by this paper
• AP-1 in cell proliferation and survival

  2001cited by this paper
• Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expression.

  2000cited by this paper
• Expression of cell cycle–regulatory proteins Rb, p16/MTS1, p27/KIP1, p21/WAF1, cyclin D1 and cyclin E in breast cancer: Correlations with expression of activating protein‐1 family members

  2000cited by this paper
• Cell cycle‐dependent variations in c‐Jun and JunB phosphorylation: a role in the control of cyclin D1 expression

  2000cited by this paper
• c‐Jun regulates cell cycle progression and apoptosis by distinct mechanisms

  1999cited by this paper
• Control of cell cycle progression by c-Jun is p53 dependent.

  1999cited by this paper
• Cell cycle proteins and the development of oral squamous cell carcinoma.

  1999cited by this paper
• Fos Family Members Induce Cell Cycle Entry by Activating Cyclin D1

  1998cited by this paper
• AP-1 function and regulation.

  1997cited by this paper
• Transformation by ras modifies AP1 composition and activity

  1997cited by this paper
• Histological Typing of Cancer and Precancer of the Oral Mucosa

  1997cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture.

  1993cited by this paper
• The jun and fos protein families are both required for cell cycle progression in fibroblasts

  1991cited by this paper

• Photobiomodulation Exerts Anti‐Inflammatory and Antioxidant Effects Reducing the Development of Tumors Elicited by 4‐NQO in the Mice Tongue

  2025cites this paper
• The effect of c-Fos on the prognosis, proliferation, and invasion of oral squamous cell carcinoma.

  2024cites this paper
• Molecular Markers in Epithelial Dysplasia as Predictors of Malignant Transformation: A Review

  2024cites this paper
• A meta-analysis reveals the protein profile associated with malignant transformation of oral leukoplakia

  2023cites this paper
• Role of E2F transcription factor in Oral cancer: Recent Insight and Advancements.

  2023cites this paper
• c-FOS Expression Analysis in Pterygia Cell Spot Arrays

  2022cites this paper
• Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia

  2022cites this paper
• A REVIEW ON REGULATORY PROTEINS AS POTENTIAL SALIVARY BIOMARKERS IN ORAL CANCER DETECTION

  2021cites this paper
• C-Fos Digital Expression Analysis in Human PapillomavirusRelated Oral Squamous Cell Carcinoma

  2021cites this paper
• SOX2-dependent expression of dihydroorotate dehydrogenase regulates oral squamous cell carcinoma cell proliferation

  2021cites this paper
• Expression of Cyclin D1 in oral squamous cell carcinoma and its correlation with histopathological differentiation

  2020cites this paper
• Significance of Expression of Cyclin D as an Early Indicator in Dysplastic Transformation of Oral Mucosa in Tobacco Users

  2019cites this paper
• Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders

  2019cites this paper
• Expression of cornulin in oral premalignant lesions.

  2019cites this paper
• Bufadienolides from Venenum Bufonis Inhibit mTOR-Mediated Cyclin D1 and Retinoblastoma Protein Leading to Arrest of Cell Cycle in Cancer Cells

  2018cites this paper
• Differential Expression of c-fos Proto-Oncogene in Normal Oral Mucosa versus Squamous Cell Carcinoma

  2018cites this paper
• Predicting the outcome of oral, potentially malignant, disorders using a composite clinical, histopathological and molecular classifier

  2018cites this paper
• Oncogene c‐fos and mutant R175H p53 regulate expression of Nucleophosmin implicating cancer manifestation

  2018cites this paper
• Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.

  2017cites this paper
• Comparative Investigation of Ki67 Marker in Oral Squamous Cell Carcinoma and Oral Lichen Planus by Immunohistochemistry

  2017cites this paper
• Comparative Investigation of Cyclin D1 Marker in Oral Squamous Cell Carcinoma and Oral Lichen Planus

  2017cites this paper
• c-Jun, pc-Jun, and p27 are differently expressed in oral leukoplakias in smokers and never-smokers.

  2016cites this paper
• Combined Expression of c-jun, c-fos, and p53 Improves Estimation of Prognosis in Oral Squamous Cell Carcinoma

  2016cites this paper
• Expression of Cornulin, DPEP1, SOX4 and BUB3 in Oral Premalignant Lesions

  2016cites this paper
• Molecular Pathology Signatures in Predicting Malignant Potentiality of Dysplastic Oral Pre-cancers

  2015cites this paper
• Genomics, Personalized Medicine and Oral Disease

  2015cites this paper
• Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer

  2015cites this paper
• Cyclin D1 and Ki-67 expression correlates to tumor staging in tongue squamous cell carcinoma

  2015cites this paper
• Cyclin D 1 Expression and Its Correlation with Histopathological Differentiation in Oral Squamous Cell Carcinoma

  2014cites this paper
• Cyclin d1 gene expression in oral mucosa of tobacco chewers"-an immunohistochemical study.

  2014influential citation
• 1α,25-Dihydroxyvitamin D3 Modulates CYP2R1 Gene Expression in Human Oral Squamous Cell Carcinoma Tumor Cells

  2014cites this paper
• Expressão imuno-histoquímica das proteínas Jab1, p27, c-jun e c-fos no adenoma pleomórfico, adenocarcinoma polimorfo de baixo grau e carcinoma adenoide cístico das glândulas salivares

  2014cites this paper
• Potentially malignant disorders of the oral cavity: Current practice and future directions in the clinic and laboratory

  2014cites this paper
• Avocado Extract Inhibits 7, 12-Dimethylbenz(a)anthracene (DMBA)- Induced Carcinogenesis in Hamster Cheek Pouches

  2014cites this paper
• COMPARATIVE INVESTIGATION OF CYCLIN D1 EXPRESSION IN ORAL LICHEN PLANUS AND SQUAMOUS CELL CARCINOMA BY IMMUNOHISTOCHEMISTERY TECHNIQUE

  2014cites this paper
• Bioinformatics and systems biology analysis of genes network involved in OLP (Oral Lichen Planus) pathogenesis.

  2013cites this paper
• Advances in monoclonal antibody application in myocarditis

  2013cites this paper
• Expression of Caspase 14 and Filaggrin in Oral Squamous Carcinoma

  2013cites this paper
• The importance of oncogenic transcription factors for oral cancer pathogenesis and treatment.

  2013cites this paper
• Análise comparativa da expressão imuno-histoquímica da via PI3K-AKT-mTOR em displasias epiteliais, lesões irritativas e carcinomas espinocelulares

  2013cites this paper
• O potencial translacional dos biomarcadores na abordagem da leucoplasia oral

  2013cites this paper
• Can Immunohistochemistry Serve as an Alternative to Subjective Histopathological Diagnosis of Oral Epithelial Dysplasia?

  2013cites this paper
• Immunoexpression of Ki67 and cyclin D1 in oral squamous carcinomas.

  2012cites this paper
• Molecular Biology of Head and Neck Cancer: Therapeutic Implications

  2012cites this paper
• Cyclin D1 Expression and Its Correlation with Histopathological Differentiation in Oral Squamous Cell Carcinoma

  2012influential citation
• Ras Signaling Pathway in the Chemopreventive Action of Different Ratios of Fish Oil and Corn Oil in Experimentally Induced Colon Carcinogenesis

  2012cites this paper
• Expressão imunohistoquímica das proteínas c-Jun não fosforilada/fosforilada e p27 em leucoplasias de pacientes fumantes e não fumantes

  2012cites this paper
• HPV16E6-Dependent c-Fos Expression Contributes to AP-1 Complex Formation in SiHa Cells

  2011influential citation
• Genetics/epigenetics of oral premalignancy: current status and future research.

  2011cites this paper
• Reviewsynthase kinase 3 beta: can it be a target for oral cancer

  2010cites this paper
• The expression and significance of proto-oncogene c-fos in viral myocarditis

  2010cites this paper
• Microcystin-LR activates the ERK1/2 kinases and stimulates the proliferation of the monkey kidney-derived cell line Vero-E6.

  2010cites this paper
• Biomarkers in tongue cancer: understanding the molecular basis and their clinical implications

  2010cites this paper
• Gene expression analysis by cDNA microarray in oral cancers from two Western populations.

  2010cites this paper
• Main Molecular Markers of Oral Squamous Cell Carcinoma

  2010cites this paper
• Glycogen synthase kinase 3 beta: can it be a target for oral cancer

  2010cites this paper
• Molecular markers in oral epithelial dysplasia: review.

  2009cites this paper
• Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.

  2009cites this paper
• COMPARAÇÃO IMUNOISTOQUÍMICA DAS EXPRESSÕES DAS PROTEÍNAS P27 E C-JUN NA CARCINOGÊNESE INTRA-ORAL

  2009cites this paper
• A Novel Function of CXCL 13 to Stimulate RANK Ligand Expression in Oral Squamous Cell Carcinoma Cells

  2009cites this paper
• Transactivation and expression patterns of Jun and Fos/AP‐1 super‐family proteins in human oral cancer

  2009cites this paper
• Diabetes enhances the expression of H-ras and suppresses the expression of EGFR leading to increased cell proliferation.

  2009cites this paper
• A Novel Function of CXCL13 to Stimulate RANK Ligand Expression in Oral Squamous Cell Carcinoma Cells

  2009cites this paper
• Animal Models of Oral Squamous Cell Carcinoma

  2008cites this paper
• The hamster model of sequential oral oncogenesis.

  2008cites this paper
• H-ras and c-fos exhibit similar expression patterns during most stages of oral oncogenesis.

  2008cites this paper
• Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy

  2008cites this paper
• Correlation between c-Jun and human papillomavirus in oral premalignant and malignant lesions.

  2008cites this paper
• Progressive rise of c fos expression from premalignant to malignant lesions of oral cavity.

  2008cites this paper
• Use of carcinogen-induced premalignant oral lesions in a dendritic cell-based vaccine to stimulate immune reactivity against both premalignant oral lesions and oral cancer.

  2008cites this paper
• Autocrine motility-stimulatory pathways of oral premalignant lesion cells

  2007cites this paper
• EGFR and c-Jun exhibit the same pattern of expression and increase gradually during the progress of oral oncogenesis.

  2007cites this paper
• Oral premalignant lesions induce immune reactivity to both premalignant oral lesions and head and neck squamous cell carcinoma

  2007cites this paper
• Diabetes and oral oncogenesis.

  2007cites this paper
• RETINOBLASTOMA E PESQUISA DO HPV EM CARCINOMAS EPIDERMÓIDES BUCAIS

  2006cites this paper